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Purpose: This study was designed as a prospective multicenter randomized comparison of procedure-related complica-
tions, patient recuperation, and quality-of-life outcomes between patients undergoing vein stripping with high ligation
and patients undergoing great saphenous vein (GSV) obliteration with temperature-controlled radiofrequency ablation
without adjunctive high ligation (Closure procedure).
Methods: Eighty-five patients (86 limbs) from five sites (France, 2; Austria, 1; United States, 2) were randomly allocated
to undergo radiofrequency obliteration (RFO) or stripping and high ligation (S&L). Final analysis included data for 44
limbs in the RFO group and 36 limbs in the S&L group. Follow-up examinations were performed at 72 hours, 1 week,
3 weeks, and 4 months. All patients completed the CIVIQ2 quality-of-life (QOL) questionnaire and underwent clinical
and ultrasound examinations at each follow-up visit.
Results: Immediate success on the day of treatment was reported for 95% (42 of 44) of limbs in the RFO group and 100%
(36 of 36) of limbs in the S&L group. In seven RFO limbs (16.3%) a scan obtained 72 hours after the procedure showed
flow in the proximal GSV. Five of these segments had reflux in the open segment. At 1 week two of these closed, and an
additional segment closed at 3 weeks. In no cases did flow reappear after complete occlusion of the GSV. Time to return
to normal activities was significantly less in the RFO group (mean, 1.15 days; 95% confidence interval [CI], 0.05-2.34)
compared with the S&L group (mean, 3.89 days; CI, 2.67-5.12; P .02). In the RFO group, 80.5% of patients returned
to routine activities of daily living within 1 day, compared with 46.9% of patients in the S&L group (P < .01). Patients
in the RFO group were able to return to work in 4.7 days (CI, 1.16-8.17), compared with 12.4 days (CI, 8.66-16.23)
for the S&L group (P< .05). Analysis of the QOL surveys showed statistically significant differences in favor of the RFO
group for global score and pain score during follow-up. The magnitude of the difference, however, progressively
decreased between 1 week and 4 months.
Conclusions: In the absence of significant complications, such as deep vein thrombosis and pulmonary embolism, severe
neuritic sequelae, and skin burns, there are significant early advantages to endovascular obliteration of the GSV compared
with conventional vein stripping. (J Vasc Surg 2003;38:207–14.)
Conventional management of the incompetent saphe-
nous vein in patients with symptomatic varicose veins is
generally believed to be best treated with removal of the
saphenous vein from the saphenofemoral junction to the
level of the knee or below, along with individual ligation of
the saphenous branches in the groin. Ligation and stripping
is the standard treatment for varicose veins, with the highest
rate of initial success and lowest rate of recurrence.1,2 Any
alternative technique to high ligation and stripping of the
saphenous vein must have the same or better outcome,
ideally without the associated morbidity. A new approach
to management of saphenous vein reflux is endovascular
obliteration of the vein with a radiofrequency-generated
heating probe placed through a percutaneous puncture or
mini-incision in the calf. This is known as the Closure
procedure (VNUS Medical Technologies, San Jose, Cal-
if).3-6 We present early results of a comparative study of
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conventional stripping versus the Closure procedure in a
prospective randomized format designed to record intraop-
erative and immediate postoperative results of these quite
different therapies. The limited follow-up of 4 months is
adequate to define early response to each procedure.
Important comparisons between these two procedures
are obliteration of the saphenous trunk with the endovas-
cular approach versus removal of the vein in the stripping
procedure, and sealing of the branches by means of internal
heating (“internal ligation”) with the Closure procedure
versus external ligation outside of the vein with the strip-
ping technique. In addition, the highest branch of the
saphenous vein, usually the superficial epigastric branch, is
left patent as it drains into the saphenous vein adjacent to
the saphenofemoral junction in the Closure procedure.
This aspect of the Closure procedure tests the validity of the
conventional teaching that every branch of the saphe-
nofemoral junction must be individually ligated to lower
incidence of recurrence in the groin.
METHODS AND MATERIALS
This study was designed as a prospective multicenter
randomized comparison of procedure-related complica-
tions, patient recuperation, and QOL outcomes between
patients undergoing conventional vein stripping with high
ligation (S&L) compared with patients undergoing great
saphenous vein (GSV) obliteration with temperature-con-
trolled radiofrequency obliteration (RFO) without adjunc-
tive high ligation (Closure procedure).
Five widely dispersed sites (France, 2; Austria, 1;
United States, 2) volunteered to cooperate in this study.
Each site had performed at least 15 Closure procedures and
had been proctored by representatives of VNUS Medical
Technologies in performance of the technique, to provide
continuity among sites in performance of the operation.
These sites had previous experience with S&L as the histor-
ically preferred method of treatment of incompetent saphe-
nous veins, and had a known professional reputation, sci-
entific interest, and experience in clinical research in venous
disease. Inclusion and exclusion criteria for the limbs to be
treated were developed by the investigators in cooperation
with VNUSMedical Technologies. The company provided
financial support for data collection, clinical monitors, and
disposable catheters free of charge.
Randomization was allocated via internet. The internet
site was audited regularly to detect redundant randomiza-
tion activity.
The purpose of the study was to compare intraoperative
and early (4 month) postoperative experiences of treatment
of comparable cases with S&L or RFO (Closure procedure)
with a controlled radiofrequency current according to the
protocol of VNUS Medical Technologies.
The study was approved by the Ethics Committee of
each institution.
Study population. Eligible patients had symptomatic
varicose veins and GSV incompetence, confirmed with
duplex ultrasound scanning, and were candidates for con-
ventional vein stripping and qualified under the inclusion
and exclusion criteria of the study.
Inclusion criteria were as follows:
Reverse flow in the GSV lasting longer than 0.5 seconds in
the standing position, as routinely used for definition of
GSV incompetence by all investigators
Age between 21 and 80 years
CEAP7 clinical classification C2, C3, or C4
Ambulatory status
Segmental deep reflux allowable
Saphenous vein diameter less than or equal to 1.2 cm in the
supine position
Availability for follow-up visits at 72 hours, 1 week, 3
weeks, and 4 months
Exclusion criteria were as follows:
Vein diameter greater than 1.2 cm or less than 0.2 cm
Duplication of saphenous trunk or incompetent accessory
saphenous branch
Small saphenous vein reflux
Varices of the thigh
Previous deep venous thrombosis
Arterial insufficiency (ankle-brachial index [ABI]  0.9)
Axial deep venous reflux, from groin through popliteal vein
Tortuosity of the GSV segment to be treated, subjectively
assessed on the basis of appearance and ultrasound scan
as unsuitable for catheterization
Investigation protocol. Signs and symptoms were re-
corded by a physician who used the clinical severity score
(VCSS) described by Rutherford et al.8 Each of 10 descrip-
tors was ranked as 0 (absent), 1 (mild), 2 (moderate), or 3
(severe). The range of possible scores was 0 to 30. The
physician also recorded the CEAP classification.
Each patient completed the 20-question CIVIQ2
QOL questionnaire, which has been validated for use in
patients with chronic venous disease.9,10 Response to each
question was rated on a scale of 1 to 5, where 1 represents
minimal negative effect on daily activities and well-being
and 5 represents maximum negative effect. Each question
was classified in one of four dimensions: Pain, Physical,
Social, or Psychological; and the four dimensions were
combined to form a single global score. At data analysis,
each dimension score and the global scores were trans-
formed to a scale of 0 to 100,9 where 0 represents the least
possible effect on daily activities and well-being, ie, highest
QOL, and 100 represents maximum negative effect.
Primary end points included QOL score at each fol-
low-up examination, time until return to routine activities,
time until return to work, and recording of adverse se-
quelae related to the procedure.
Treatment. Treatment of the GSV was performed
from the knee or upper calf to the saphenofemoral junction
in both S&L and Closure procedures. Adjunctive proce-
dures on varices and perforator vessels were limited to sites
below the knee. Varices and perforator vessels above the
knee were not treated, to prevent confusion postoperatively
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between morbidity due to saphenous vein treatment with
RFO versus S&L and that due to the adjunctive procedure.
Bilateral treatment was permitted, provided each limb
received the same treatment and both limbs were treated
during the same operation.
For patients randomized to RFO, the Closure catheter
and system (VNUS Medical Technologies) was used ac-
cording to described methods.4,5 For patients randomized
to S&L, physicians followed their standard practice, using
either an olive-tipped device or a perforate invagination
(PIN) stripper. The learning curve was minimized by en-
suring that all participants were proficient in performing
both S&L and the Closure procedure. Variability in indi-
vidual stripping techniques was accepted as reflective of
“real world” comparison of the standard Closure technique
versus individual approaches to stripping. The type of an-
esthetic used varied between centers and included either
tumescence infiltration with or without regional anesthesia,
or general anesthesia.
Technical success of treatment was monitored with
repeated ultrasound duplex scanning. Criteria for success-
ful treatment included elimination of the GSV with the
stripping procedure and obliteration of the lumen with
echogenic material in the Closure procedure. In the RFO
group the treatment starting point, and therefore the prox-
imal obliteration point, was located distal to the saphe-
nofemoral junction just below the entrance of the highest
branch. For purposes of judging the postoperative scan,
successful RFOwas less than 5 cm of GSV patency from the
saphenofemoral junction, with the distance measured from
the junction along the curve of the GSV to the proximal
obliteration point.
All patients, regardless of treatment assignment, were
encouraged to return to their usual level of physical activity
as soon as possible.
Follow-up. Postoperative follow-up was at 72 hours,
1 week, 3 weeks, and 4 months. Each visit included a
clinical examination by a physician, duplex ultrasound scan-
ning by an expert sonographer, and completion of the
20-question CIVIQ2 QOL questionnaire by the patient.
Study monitoring. Operation records and patient
charts were reviewed by the sponsor (VNUSMedical Tech-
nologies) for completion of study data points. During and
after data acquisition two investigators (L.K., F.L.) con-
ducted a thorough audit of raw data handling and storage
methods, data processing accuracy, and presentation of
specific results. They reported all of these in order and that
results accurately reflected raw data received from the in-
vestigator sites. The sponsor provided support for all of
these functions and responded to specific inquiries during
the course of analysis and preparation of this article, but did
not interfere with analysis of data or formulation of
conclusions.
Statistical methods. VCSS scores and health- related
QOL dimension and global mean scores were analyzed
with one-way analysis of variance and the Tukey-Kramer
test. Repeated measures analysis of variance was used to
compare scores before treatment (baseline) and scores after
treatment. Alternatively, the absolute difference between
baseline score and score after treatment for each individual
patient was used to analyze the difference between groups.
The general linear model of SPSS software (version 10.1;
SPSS, Chicago, Ill) was used to compare QOL scores
between groups at 72 hours after treatment to adjust for
confounding variables (type of anesthesia, number of ad-
junctive procedures). The Cochran Q test and Mantel-
Haenszel method were used to compare frequency of com-
plications and adverse findings at each follow-up interval.
The Student t test and Fisher exact test were also used when
appropriate. Values represent mean  SD or 95% confi-
dence interval.
RESULTS
Patients were enrolled from August 2000 through Oc-
tober 2001. Of 85 patients (86 limbs) enrolled, 45 patients
(46 limbs) were allocated to the RFO group and 40 pa-
tients to the S&L group. Three patients in the S&L arm,
after receiving allocation notification, excluded themselves
from the study before treatment. This reflected a problem
with recruitment during the study due to patient reluctance
to be blindly allocated to one or the other arm. One
additional patient randomized to the S&L arm had re-
peated scheduling delays and failed to receive treatment
over the entire study period. One patient in the RFO group
was excluded after randomization when the physician
learned of a previous surgical intervention in the target
vein. The final result of these allocation problems was that
RFOwas performed in 45 limbs and S&Lwas performed in
36 limbs. Final distribution of cases among the participat-
ing sites is shown in Table I. There were no crossover or
aborted procedures. Venous disease in one patient in the
RFO group was classified as CEAP C6, which was a proto-
col violation, and data for this patient were not included in
the final analysis.
Similarity between the two patient groups in terms of
demographics, CEAP classification, and clinical severity of
venous disease is shown in Table II.
Procedural details, including anesthesia type, adjunc-
tive procedures, and length of saphenous vein segment
treated, are summarized in Table III. The original intent
was to compare treatment time for the two techniques, but
rules of recording separately venous access time, treatment
time, and adjunctive procedure time were not uniformly
Table I. Distribution of cases among participating sites
Sites
No. of cases
RFO S&L Total/site
1 20 14 34
2 6 9 15
3 7 7 14
4 9 3 12
5 2 3 5
Total 44 36 80
RFO, Radiofrequency obliteration; S&L, stripping and ligation.
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followed. As a result, total treatment time for the S&L
group was confused with isolated Closure treatment time in
the RFO group. Closure treatment time, including vein
access time of 41  5 minutes, is reported as an isolated
statistic, whereas total treatment time for the two groups
was 74 10 minutes for Closure and 89 12 minutes for
S&L. Since the number of phlebectomies and perforator
vessel procedures were comparable between the two
groups, total operating times represent a reasonable com-
parison of operating times.
There was a significant difference in anesthetic tech-
nique between the two groups, with general anesthesia
used in 27% of patients in the RFO group and 53% of
patients in the S&L group. Moreover, average number of
phlebectomies per limb was significantly higher in patients
who received general anesthetic (mean, 11.7; 95% CI,
8.5-14.9) compared with those who received local or re-
gional anesthetic (mean, 7.2; 95% CI, 4.9-9.4). Perforator
vessel interruption was performed only with the patient
under general anesthesia in this study (2.3 1.5 per limb).
Therefore all comparisons between QOL scores in the two
groups (RFO vs S&L) were adjusted for type of anesthesia
and number of adjunctive procedures.
Management of the proximal end of the GSV was with
surgical dissection and separate ligation of all saphenous
branches in the femoral triangle in the S&L group and
nonsurgical endovenous obliteration in the RFO group.
The endovenous technique typically results in obliteration
of all but the highest branch of the GSV, which usually
means that the superficial epigastric branch is left patent.
Treatment flush with the common femoral vein (CFV) is
not recommended because of possible thermal injury to the
CFV, which could lead to local thrombosis or later stenosis
of the CFV. There were no instances of CFV thrombosis or
other injury in RFO cases in this study, as confirmed at
repeated postoperative duplex scanning.
In technique comparisons, vein access of the distal
extent of the saphenous vein in the calf was with cutdown in
all limbs in the S&L group and in 43% (19 of 44) of limbs
in the RFO group; the other 25 limbs in the RFO group
were accessed via percutaneous puncture of the GSV in the
calf with ultrasound-guided technique and did not require
a calf incision.
Procedural complications were infrequent in both
groups. One intraoperative hematoma was reported in each
of the two groups, one vein perforation was reported in the
RFO group, and two vein tears were reported in the S&L
group. There were no thermal injuries or perioperative
hemorrhage in either treatment arm.
Immediate success on the day of treatment was re-
ported in 95% (42 of 44) of RFO limbs and in 100% (36 of
36) of S&L limbs. The two failures in the RFO group were
technical; there was failure of passage of the catheter all the
way to the saphenofemoral junction, with the result that
the upper 10 cm of the GSV was left untreated in one limb
and there was indeterminate shrinkage of the GSV in
another limb because a small (5 F) catheter was used
inappropriately in a large vein with internal diameter of 8.6
mm. In both of these limbs reflux was demonstrated on
postoperative scans and is reported as such in outcome
statistics. One S&L case could not be confirmed as success-
ful on the basis of the completion scan, because visualiza-
tion of the groin was obscured by technical factors, but was
found to be successful on all subsequent scans.
Postoperative follow-up. In the RFO group, postop-
erative follow-up examinations were performed in 44 limbs
at 72 hours, 43 limbs at 1 week, 44 limbs at 3 weeks, and 43
limbs at 4 months; and in the S&L group, follow-up
examinations were performed in 36 limbs at 72 hours, 36
limbs at 1 week, 36 limbs at 3 weeks, and 34 limbs at 4
months. The QOL questionnaire was completed in all but
eight instances: one at initial follow-up and four at 4
months in the S&L arm, and one each at 1 week, 3 weeks,
and 4 months in the RFO arm. Subsequent efforts to
retrieve these results were not successful.
Clinical follow-up data. Two important statistics in
the two groups were time until return to normal activity
and time until return to work, because significant differ-
ences were reported. Time until return to normal activity
was significantly less in the RFO group (mean, 1.15 days;
95% CI, 0.05-2.34) compared with the S&L group (mean,
Table II. Demographics, VCSS, and maximum CEAP
before treatment
RFO (N  44) S&L (N  36)
P(mean  SD) (mean  SD)
Age (y) 49  4 47  4 NS
VCSS 4.80  0.34 4.39  0.38 NS
n (%) n (%)
Female gender 32 (74.4) 26 (72.2) NS
Self-reported as working 25 (58.1) 25 (69.4) NS
CEAP
2 36 (81.8) 28 (77.8) NS
3 4 (9.1) 4 (11.1) NS
4 4 (9.1) 4 (11.1) NS
RFO, Radiofrequency obliteration; S&L, stripping and ligation; VCSS,
venous clinical severity score; NS, not significant.
Table III. Anesthesia type, adjunctive procedures, length
of segment treated
RFO S&L
n (%) n (%)
Anesthesia type
Regional or local (includes
tumescent)
32 (72.7) 17 (47.2)
General 12 (27.3) 19 (52.8)
Adjunctive procedures
None 2 (4.5) 0 (0)
Phlebectomy 42 (95.5) 36 (100)
Perforator interruption 2 (4.5) 5 (13.9)
Mean  SD Mean  SD
Number of avulsions per
extremity
8.6  2.6 9.8  2.8]
Mean length of segment
treated (cm)
37  2 40  2
RFO, Radiofrequency obliteration; S&L, stripping and ligation.
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3.89 days; 95% CI, 2.67-5.12; P  .02). These figures are
adjusted for type of anesthetic and number of adjunctive
procedures performed, each of which influenced the re-
sults. In the RFO group, patients given general anesthetic
returned to normal activity in 1.36 0.92 days, compared
with 0.93  1.02 days for patients given local or regional
anesthetic; and in the S&L group, patients given general
anesthetic returned to normal activity in 6.65 6.76 days,
compared with 1.14 0.36 days for patients given local or
regional anesthetic (Table IV). In other words, 80.5% of
patients in the RFO group returned to routine activities of
daily living within 1 day, compared with 46.9% of patients
in the S&L group (P  .01).
Mean values for return to work in the RFO group were
4.7 days (95% CI, 1.16-8.17) compared with 12.4 days
(95% CI, 8.66-16.23) in the S&L group (P  .05). This
result was not influenced by type of anesthetic (P  .58)
and was not significantly associated with number of adjunc-
tive procedures (P  .72). Time until return to normal
activity and return to work values were not significantly
different between sites. Complications and adverse findings
reported at 72 hours, 1 week, and 3 weeks are presented in
Table V. By 4-month follow-up there were no differences
to report; thus these results are not detailed in the table.
Absence of all complications and adverse findings asso-
ciated with a given procedure was included as one measure,
and this was consistently favorable to the RFO group, with
statistical significance throughout the 3-week follow-up
but completely disappeared at the 4-month follow-up. Of
the other individual categories, RFOwas favored in tender-
ness, ecchymosis, and hematoma by significant margins.
The S&L group was favored by nonsignificant margins in
the paresthesia category through the 3-week follow-up, but
these differences were negligible at the 4-month follow-up.
In patients with postoperative hematoma, estimation of
degree of postoperative discomfort was patient-assessed at
72 hours and 1 week with a visual analog scale of 0 to 10 in
seven patients in the RFOgroup and 13 patients in the S&L
group. The comparison showed a trend for greater discom-
fort in the S&L group, but this was not statistically
significant.
Four-month follow-up reports were available for 43
limbs in the RFO group and 34 limbs in the S&L group. At
4 months, 83.7% (36 of 43) RFO limbs and 76.5% (26 of
34) S&L limbs had no complications. Lingering findings
included ecchymosis (n  1), erythema (n  2), and
hematoma (n  3), all in the S&L group. These were not
deemed significant. No other complications were noted.
Complications other than those shown in Table V were
minimal. There were no instances of deep vein thrombosis
(at duplex scanning) or clinical pulmonary embolism, no
thermal injuries, and no lymphatic complications. In the
S&L arm one patient had a minor groin infection, which
resolved quickly with antibiotic therapy, and one patient
had an infection of the thigh and calf and required hospi-
talization for debridement and antibiotic therapy. The in-
fection resolved between the 3-week and 4-month fol-
low-up examinations. There were no postoperative
hospitalizations in the RFO group.
Ultrasound follow-up. Comparative postoperative
results for length of GSV occlusion, residual patent seg-
ments, and reflux findings are included in the ultrasound
category.
All limbs in the S&L group were free of reflux at 72
hours and 1 week.
Postoperative ultrasound findings were analyzed in 43
patients in the RFO group. Because of deficiency in the case
report, data for one patient were excluded from analysis. In
that case, flow in the proximal segment was reported at 72
hours, but the length of the patent segment was not re-
ported. There was no reflux in this segment, and flow was
not detectable at 1-week follow-up or thereafter. There
were also two missing data points, in one case at 1-week
follow-up and in another at 4-month follow-up.
In the RFO group 36 of 43 limbs satisfied criteria for
complete GSV occlusion (5 cm of proximal patent vein
and no reflux in the patent segment) at 72 hours. In 7 of
these limbs flow was detected in the proximal 0.5 to 3.4 cm
(mean, 2.3 cm) GSV segment. Flow was undetectable at 1
week in two of these limbs, at 3 weeks in two limbs, and at
4 months in one limb. The other two limbs demonstrated
flow (2 and 4 cm, respectively) in the proximal segment of
the GSV. In none of 36 limbs did flow recur.
In seven (16.3%) of 43 limbs, the 72-hour scan showed
flow in the proximal GSV. All seven limbs had flow in the
proximal segment of the GSV, but only five limbs had reflux
in the open segment. Six of these segments were longer
than 5 cm (mean, 21.4 cm; maximum, 34 cm). At 1 week
two of these segments closed, and one additional segment
closed at 3 weeks. Four limbs (9.5%) were left with open
segments and are considered technically incomplete clo-
sures. These limbs were all asymptomatic at 4-month fol-
low-up, and the ultimate clinical course remains to be seen.
Patency and reflux in branch veins were not addressed in
this protocol.
The diameter of occluded proximal GSV measured
with ultrasound showed progressive shrinkage: 3.5 mm at
72 hours, 3.0 mm at 3 weeks, and 2.2 mm at 4 months.
Physician and patient assessment of outcome and com-
pliance with wearing stockings were similar throughout the
study. The cosmetic assessment after RFO was consistently
Table IV. Distribution of patients in groups by time until
return to normal physical activity after surgery
Group Anesthesia
Percent of patients who returned to
normal physical activity at different
time after surgery
Same
day
1-3
days
3-5
days
5-15
days
15
days
RFO General (n  11) 9 91 — — —
Local (n  30) 33 64 3 — —
S&L General (n  17) — 41 18 23 18
Local (n  15) — 100 — — —
RFO, Radiofrequency obliteration; S&L, stripping and ligation.
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better than after S&L, to a significant degree. Signs and
symptoms reported by patients were similar in all but the
pain category, in which RFO showed a clear advantage.
This was subjective assessment of pain, which was not
measured routinely with an analog scale or consumption of
pain pills, but was recorded with the VCSS. All other
measures were virtual mirror images between the two study
groups.
Analysis of QOL surveys showed that statistically sig-
nificant differences in favor of the RFO group were present
in global score and pain score during follow-up. The mag-
nitude of the difference, however, progressively decreased
from 1 week to 3 weeks and was negligible at 4 months.
Differences in global, pain, and physical scores on the
QOL instrument, where statistically significant results were
found, are shown in Table VI. The figures were adjusted for
number of adjunctive procedures. Inasmuch as social and
psychologic scores did not show significant differences, the
difference in the global score was entirely due to changes in
scores for pain and physical activity.
Analysis of the effect of type of anesthetic used showed
that the chances of QOL score improvement at 72 hours
after treatment were significantly higher in the Closure
group (P  .016), regardless of anesthetic type (general or
local with sedation; Table VII). When treatment was per-
formed with the patient under general anesthesia the
chances of QOL global score improvement were six times
higher in the RFO group (odds ratio [OR], 6.0; 95% CI,
1.2-30.3), and the chances of physical activity score im-
provement were 10 times higher (OR, 10.0; 95% CI,
1.9-58.8), compared with the S&L group.
DISCUSSION
Rutgers and Kitslaar1 and Jones et al2 showed in sepa-
rate randomized studies that high ligation with saphenec-
tomy resulted in lower recurrence rate of reflux and vari-
cosities than did high ligation alone. Because of morbidity
consisting of post-procedural pain and bruising that re-
sulted from the stripping procedure, modifications of the
conventional stripping technique have been sought. PIN
stripping is one such technique that has been embraced by
many. Prospective randomized studies by LaCroix et al11
and by Durkin et al12 compared post-procedural morbidity
rates between PIN stripping and conventional (olive tip)
stripping and reported an absence of clear benefit from the
new technique except that the exit wound is smaller with
the PIN technique.12 The present standard remains high
ligation with stripping with either technique, and any alter-
native technique will need to demonstrate equal or better
outcome with equal or reduced morbidity to be accepted.
Table V. Complications and adverse findings reported through 3-week follow-up
Complications and adverse
findings
Follow-up
72 h 1 wk 3 wk
RFO S&L RFO S&L RFO S&L
n % n % P n % n % P n % n % P
None 19 43.2 6 16.7 .05 15 34.9 5 13.9 .05 31 70.5 14 38.9 .01
Infection 0 0 2 5.6 0 0 1 2.8 0 0 1 2.8
Superficial venous thrombosis 0 0 1 2.8 1 2.3 2 5.6 2 4.5 1 2.8
Tenderness 2 4.5 9 25.0 .01 5 11.6 10 27.8 4 9.1 9 25.0
Lymphocele 0 0 0 0 0 0 1 2.8 0 0 0 0
Bleeding from stab wound 3 6.8 3 8.3 0 0 0 0 0 0 0 0
Ecchymosis 12 27.3 19 52.8 .05 14 32.6 23 63.9 .01 1 2.3 7 19.4 .05
Erythema 6 13.6 3 8.3 2 4.7 1 2.8 1 2.3 3 8.3
Hematoma 7 15.9 14 38.9 .05 6 14.0 18 50.0 .01 1 2.3 12 33.3 .01
Paresthesia 5 11.4 2 5.6 10 23.3 5 13.9 7 15.9 2 5.6
Hyperpigmentation 0 0 0 0 0 0 0 0 1 2.3 0 0
RFO, Radiofrequency obliteration; S&L, stripping and ligation.
Table VI. Differences in global score and in Pain and
Physical activity dimensions of quality-of-life
measurement
Follow-up
S&L RFO
PMean SE Mean SE
72 h Difference in
global score*
13.3 3.1 3 2.7 .0001
Difference in
pain*
2.9 0.7 1.77 0.6 .0001
Difference in
physical score*
4.85 0.79 0.82 0.69 .0001
1 wk Difference in
global score†
3.7 2.5 9.2 2.3 .0001
Difference in
pain†
1.2 0.7 2.4 0.6 .0001
Difference in
physical score†
2.02 0.72 0.97 0.65 .003
S&L, Stripping and ligation; RFO, radiofrequency obliteration; QOL, qual-
ity of life.
*Differences compared with before treatment; adjusted by type of anesthesia
and number of adjuctive procedures. Positive difference indicates worsening
of QOL; negative difference indicates improvement.
†Differences compared with before treatment; adjusted by number of ajunc-
tive procedures. Positive difference indicates declination of QOL; negative
difference indicates improvement.
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This multicenter prospective randomized protocol pro-
vided direct comparison of the early postoperative course
after conventional GSV S&L and after treatment with the
Closure procedure. Because the series originated in the
early days of use of the Closure procedure, and because
improvements have been made in the procedure and the
catheter used, we believe strongly that a similar study
performed today would obviate some of the reported tech-
nical problems in the RFO group.
During early clinical application of the Closure proce-
dure some investigators observed that high ligation of the
saphenous vein and individual ligation of each of the saphe-
nous branches with open dissection might not be necessary
because this could be achieved with the endovenous route.3
The present study was performed using the Closure tech-
nique, and is known as the Endovascular Vein Occlusion
versus Ligation and Vein Stripping Study (EVOLVeS).
The instruments chosen for measurement, including
duplex scanning, QOL measurement with CIVIQ2,
CEAP, and VCSS severity scoring, are recognized as state-
of-the-art for use in venous diseases. The trial was mediated
by the sponsor to ensure comparability of the data to a
significant degree. Investigators were selected on the basis
of proficiency in performing both S&L and the Closure
procedure.
Data analysis was performed by the principal authors
independent of input from the sponsor other than to
provide access to raw data. The article was prepared by the
authors working as a group to ensure uniformity of re-
ported results and conclusions. Care was taken to eliminate
sources of sponsor influence in analysis of data. Funding
from the sponsor was limited to cost of catheters and
provision of study monitors. Reimbursement to the partic-
ipants was limited to expenses incurred.
The cogent findings in this prospective study are earlier
return to normal activity (80% vs 46% in 1 day) and earlier
return to work (4.7 days vs 12.4 days) in the Closure group.
Pain was less, recovery was quicker, early cosmesis was
better, with fewer incisions, hematomas, and ecchymoses,
and QOL analysis demonstrated significant early (up to 4
month) advantages of Closure to S&L in three of the five
categories. Complications in both arms of the study were
more annoying than serious.
The QOL instrument showed that early advantages of
Closure were statistically significant with regard to amount
of discomfort and cosmetic aspects related to the proce-
dures. The early return to normal activity followed by a
much more rapid return to work, within the first week after
RFO, are consistent and real. These attributes are not only
pleasing to the patient, but they also bear important con-
siderations for overall cost of the procedure that may offset
the higher specific costs for the Closure catheter and for
duplex scanning in the operating room. For example, cost
savings may be due to lower risk for infection. In this study,
the only patient who required hospitalization for debride-
ment and antibiotic treatment of infection was in the S&L
group. By comparison, a prospective study examining in-
fection rate in 126 patients after vein stripping performed
by 11 surgeons, all of whom were fellows of the Royal
Colleges, showed a surprisingly high overall infection rate
of 13.7%, and an infection rate of 8% even after excluding
results from two high-volume surgeons with the highest
rates.13
Critical appraisal of RFO results must conclude that
there remains room for improvement. In this series, there
were two cases in which avoidable mistakes were made in
placement of the catheter and choice of catheter size, both
of which resulted in long-term reflux in the treated seg-
ment. The finding that only 91% of veins were completely
closed in this series should be improved with further refine-
ment of the Closure technique. For example, catheter
models available today that were not available at the time of
the study track over a 0.025-inch guide wire and signifi-
cantly improve the likelihood of successfully navigating the
catheter to the saphenofemoral junction. That all veins that
were completely closed at initial follow-up remained com-
pletely closed throughout the study speaks to the efficacy of
this method in achieving obliteration of the saphenous
vein. These findings demonstrate the importance of a com-
pletely successful technical procedure in the operating
room and to the permanence of initial successful vein
obliteration.
There is an often expressed concern by the patient that
vein stripping will be painful and will leave scars, and both
of these points are addressed with the Closure technique.
The demonstration in this study that the sequelae of vein
stripping are also relatively mild and that the undesirable
effects of stripping are ameliorated within 4 months of
follow-up is testimony to the validity of this approach. In
support of vein stripping, it could be argued that there are
gentler techniques for performing vein stripping that re-
duce the aftereffects of the procedure, but our experience
probably reflects the results that are achieved in the general
care of patients who have undergone vein stripping.
Our results demonstrate that endovascular obliteration
of the GSV is a patient-friendly technique that effectively
eliminates the GSV from the circulation for at least 4
months. In the absence of significant complications, eg,
deep vein thrombosis and pulmonary embolism, severe
neuritic sequelae, and skin burn, it is evident that there are
significant early advantages to RFO compared with conven-
Table VII. Proportion of patients with improved global
score at 72-hour follow-up
Anesthesia
No
improvement
(%)
Improvement
(%)
General RFO (n  12) 25 75
S&L (n  18) 67 33
P  .03
Local or
regional
RFO (n  32) 53 47
S&L (n  17) 82 18
P  .041
RFO, Radiofrequency obliteration; S&L, stripping and ligation.
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tional S&L. The technique has limitations in terms of GSV
size and configuration, and in such cases S&L is clearly the
better choice. Longer term studies are needed to determine
the ultimate fate of the GSV after RFO, and very long-term
results will ultimately reveal the consequences of leaving
the uppermost branch of the GSV patent.
We thank Professor Robert Launois and Servier Inter-
national for permission for use the CIVIQ2 QOL assess-
ment questionnaire in our study.
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